<DOC>
	<DOC>NCT01390766</DOC>
	<brief_summary>This post-marketing surveillance (PMS) study is designed to investigate the efficacy and safety of azathioprine tablets in Japanese subjects whom liver transplantation is performed.</brief_summary>
	<brief_title>Drug Use Investigation for IMURAN (Azathioprine) Tablet (Hepatic Transplantation)</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Azathioprine</mesh_term>
	<criteria>Subjects who undergo liver transplantation and azathioprine tablet was administered As this is PMS study, there are no exclusion criteria but contraindications are as follows. Subjects with hypersensitivity to the ingredients of azathioprine tablet Subjects who is pregnant or might be pregnant Subjects whose white count is lower than 3000/cubic millimeter</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Antirejection</keyword>
</DOC>